Pharmacokinetics of fexofenadine following LPS administration to rats

References

• Ando H, Nishio Y, Ito K, Nakao A, Wang L, Zhao YL, Kitaichi K, Takagi K, Hasegawa T. (2001). Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob Agents Chemother 45:3462–3467.
   PubMedGoogle Scholar
• Bertini R, Bianchi M, Erroi A, Villa P, Ghezzi P. (1989). Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J Leukoc Biol 46:254–262.
   PubMed Web of Science ®Google Scholar
• Davey AK, Sim V, Tang EYF, Ma Z, Jaisue S, Wang J, Hiscock J. (2008). Inflammation inducted alterations in kidney structure and function. Drug Metab Rev 40:211–212.
   Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
   PubMed Web of Science ®Google Scholar
• De Paepe P, Belpaire FM, Buylaert WA. (2002). Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. Clin Pharmacokinet 41:1135–1151.
   PubMed Web of Science ®Google Scholar
• Esplugues JV, Whittle BJ. (1989). Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. Am J Physiol 256:G275–G282.
   Google Scholar
• Frost F, Roach MJ, Kushner I, Schreiber P. (2005). Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil 86:312–317.
   PubMed Web of Science ®Google Scholar
• Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK. (1999). The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104:147–153.
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Gui C. (2008). Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38:778–801.
   PubMed Web of Science ®Google Scholar
• Hamman MA, Bruce MA, Haehner-Daniels BD, Hall SD. (2001). The effect of rifampin administration on the disposition of fexofenadine. Clin Pharmacol Ther 69:114–121.
   PubMed Web of Science ®Google Scholar
• Hartmann G, Vassileva V, Piquette-Miller M. (2005). Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Drug Metab Dispos 33:820–828.
   PubMed Web of Science ®Google Scholar
• Irving K. (1982). The phenomenon of the acute phase response. Ann NY Acad Sci 389:39–48.
   PubMedGoogle Scholar
• Jepson MM, Cox M, Bates PC, Rothwell NJ, Stock MJ, Cady EB, Millward DJ. (1987). Regional blood flow and skeletal muscle energy status in endotoxemic rats. Am J Physiol 252:E581–E587.
   Google Scholar
• Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, Piquette-Miller M. (2004). Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Dispos 32:20–27.
   PubMed Web of Science ®Google Scholar
• Kamath AV, Yao M, Zhang Y, Chong S. (2005). Effect of fruit juices on the oral bioavailability of fexofenadine in rats. J Pharm Sci 94:233–239.
   PubMed Web of Science ®Google Scholar
• Kikeri D, Pennell JP, Hwang KH, Jacob AI, Richman AV, Bourgoignie JJ. (1986). Endotoxemic acute renal failure in awake rats. Am J Physiol 250:F1098–F1106.
   PubMed Web of Science ®Google Scholar
• Kozak W, Poli V, Soszynski D, Conn CA, Leon LR, Kluger MJ. (1997). Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am J Physiol Regul Integr Comp Physiol, 272. R62130.
   Google Scholar
• Leon LR, Conn CA, Glaccum M, Kluger MJ. (1996). IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am J Physiol 271:R1668–R1675.
   PubMedGoogle Scholar
• Matsushima S, Maeda K, Hayashi H, Debori Y, Schinkel AH, Schuetz JD, Kusuhara H, Sugiyama Y. (2008). Involvement of multiple efflux transporters in hepatic disposition of fexofenadine. Mol Pharmacol 73:1474–1483.
   PubMed Web of Science ®Google Scholar
• McEvoy GK (Ed.) (2004). AHFS drug information, Bethesda, MD.
   Google Scholar
• Milne RW, Larsen LA, Jørgensen KL, Bastlund J, Stretch GR, Evans AM. (2000). Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein. Pharm Res 17:1511–1515.
   PubMed Web of Science ®Google Scholar
• Mishra J, Zhang Q, Rosson JL, Moran J, Dopp JM, Neudeck BL. (2008). Lipopolysaccharide increases cell surface P-glycoprotein that exhibits diminished activity in intestinal epithelial cells. Drug Metab Dispos 36:2145–2149.
   PubMedGoogle Scholar
• Miura M, Uno T, Tateishi T, Suzuki T. (2007). Pharmacokinetics of fexofenadine enantiomers in healthy subjects. Chirality 19:223–227.
   PubMed Web of Science ®Google Scholar
• Nadai M, Matsuda I, Wang L, Itoh A, Naruhashi K, Nabeshima T, Asai M, Hasegawa T. (1998). Granulocyte colony-stimulating factor enhances endotoxin-induced decrease in biliary excretion of the antibiotic cefoperazone in rats. Antimicrob Agents Chemother 42:2178–2183.
   PubMedGoogle Scholar
• Parasrampuria R, Mehvar R. (2008). Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers. Xenobiotica 38:1263–1273.
   Web of Science ®Google Scholar
• Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. (1998). Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res 15:706–711.
   PubMed Web of Science ®Google Scholar
• Strelevitz TJ, Foti RS, Fisher MB. (2006). In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance. J Pharm Sci 95:1334–1341.
   PubMed Web of Science ®Google Scholar
• Tahara H, Kusuhara H, Fuse E, Sugiyama Y. (2005). P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion. Drug Metab Dispos 33:963–968.
   PubMed Web of Science ®Google Scholar
• Tong Y, Zhang R, Ngo SN, Davey AK. (2006). Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide. Clin Exp Pharmacol Physiol 33:685–689.
   PubMed Web of Science ®Google Scholar
• Wang P, Ba ZF, Chaudry IH. (1991). Increase in hepatic blood flow during early sepsis is due to increased portal blood flow. Am J Physiol 261:R1507–R1512.
   Google Scholar
• Wallace JL, Steel G, Whittle BJ, Lagente V, Vargaftig B. (1987). Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology 93:765–773.
   PubMed Web of Science ®Google Scholar